Simmons Bank’s AbbVie ABBV Stock Holding History

Simmons Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Sell	51,844 -618	-1%	-$133K	0.74%	36
2026 Q1	$11.4M	Buy	52,462 +1,638	+3%	+$363K	0.76%	32
2025 Q4	$11.6M	Buy	50,824 +532	+1%	+$121K	0.78%	29
2025 Q3	$11.6M	Sell	50,292 -3,210	-6%	-$654K	0.78%	31
2025 Q2	$9.93M	Sell	53,502 -1,602	-3%	-$298K	0.71%	36
2025 Q1	$11.5M	Sell	55,104 -5,848	-10%	-$1.14M	0.87%	26
2024 Q4	$10.8M	Sell	60,952 -621	-1%	-$114K	0.79%	28
2024 Q3	$12.2M	Sell	61,573 -2,507	-4%	-$468K	0.88%	25
2024 Q2	$11M	Sell	64,080 -1,004	-2%	-$166K	0.83%	26
2024 Q1	$11.9M	Sell	65,084 -574	-0.9%	-$98.9K	0.89%	27
2023 Q4	$10.2M	Sell	65,658 -315	-0.5%	-$45.9K	0.83%	29
2023 Q3	$9.83M	Buy	65,973 +1,194	+2%	+$175K	0.87%	26
2023 Q2	$8.73M	Sell	64,779 -519	-0.8%	-$76.1K	0.73%	36
2023 Q1	$10.4M	Sell	65,298 -583	-0.9%	-$89.1K	0.89%	24
2022 Q4	$10.6M	Sell	65,881 -517	-0.8%	-$79.3K	0.91%	21
2022 Q3	$8.91M	Sell	66,398 -326	-0.5%	-$46.8K	0.83%	28
2022 Q2	$10.2M	Buy	66,724 +2,262	+4%	+$346K	0.9%	27
2022 Q1	$10.4M	Buy	64,462 +1,102	+2%	+$160K	0.78%	28
2021 Q4	$8.58M	Sell	63,360 -2,268	-3%	-$268K	0.6%	40
2021 Q3	$7.08M	Buy	65,628 +2,212	+3%	+$253K	0.51%	48
2021 Q2	$7.14M	Sell	63,416 -1,520	-2%	-$171K	0.52%	52
2021 Q1	$7.03M	Sell	64,936 -2,638	-4%	-$282K	0.53%	52
2020 Q4	$7.24M	Sell	67,574 -1,685	-2%	-$162K	0.57%	46
2020 Q3	$6.07M	Sell	69,259 -4,084	-6%	-$384K	0.5%	50
2020 Q2	$7.2M	Buy	73,343 +950	+1%	+$83.6K	0.59%	43
2020 Q1	$5.52M	Buy	72,393 +1,344	+2%	+$114K	0.48%	48
2019 Q4	$6.29M	Sell	71,049 -1,189	-2%	-$98.7K	0.56%	38
2019 Q3	$5.47M	Buy	72,238 +2,622	+4%	+$180K	0.54%	42
2019 Q2	$5.06M	Buy	69,616 +7,907	+13%	+$621K	0.49%	45
2019 Q1	$4.97M	Sell	61,709 -223	-0.4%	-$18.2K	0.48%	46
2018 Q4	$5.71M	Buy	61,932 +4,834	+8%	+$425K	0.64%	37
2018 Q3	$5.4M	Sell	57,098 -903	-2%	-$85.6K	0.53%	42
2018 Q2	$5.37M	Sell	58,001 -2,942	-5%	-$287K	0.49%	41
2018 Q1	$5.77M	Buy	60,943 +14,078	+30%	+$1.55M	0.52%	37
2017 Q4	$4.53M	Sell	46,865 -828	-2%	-$78K	0.46%	43
2017 Q3	$4.24M	Buy	47,693 +4,493	+10%	+$342K	0.44%	46
2017 Q2	$3.13M	Buy	43,200 +2,335	+6%	+$157K	0.35%	57
2017 Q1	$2.66M	Sell	40,865 -1,198	-3%	-$75.3K	0.29%	63
2016 Q4	$2.63M	Buy	42,063 +1,062	+3%	+$64.8K	0.3%	68
2016 Q3	$2.59M	Buy	41,001 +93	+0.2%	+$6.02K	0.28%	70
2016 Q2	$2.53M	Buy	40,908 +1,273	+3%	+$77.6K	0.28%	70
2016 Q1	$2.26M	Buy	+39,635	New	+$2.21M	0.25%	81

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Simmons Bank's ABBV Position: Q2 2026 in Review

Simmons Bank reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $133K and leaving 51,844 shares worth $13M. The position accounts for 0.74% of the portfolio, ranked #36.

Simmons Bank first reported a position in ABBV in Q1 2016 and has held it in 42 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Simmons Bank held 51,844 shares of AbbVie worth $13M as of Q2 2026.
Simmons Bank sold 618 AbbVie shares in Q2 2026, an estimated $133K.
AbbVie made up 0.74% of Simmons Bank's portfolio in Q2 2026, its #36 holding.
Simmons Bank first reported a position in AbbVie in Q1 2016 and has held it in 42 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Simmons Bank's 13F filing for Q2 2026, filed 31 Jul 2026.